Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Discovery Platform
Recipient : AbTherx
Deal Size : Undisclosed
Deal Type : Partnership
AbTherx and Wield Therapeutics Partner to Advance New Antibody Therapies
Details : The partnership will leverage AbTherx's innovative Atlas™ Full Human Diversity Transgenic Mouse technology to deliver antibodies against a target selected by Wield.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
June 10, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Discovery Platform
Recipient : AbTherx
Deal Size : Undisclosed
Deal Type : Partnership